Ondine Biomedical Inc

OBI

Company Profile

  • Business description

    Ondine Biomedical Inc is a life sciences company, focusing on the development of photodisinfection-based therapies to provide solutions to drug-resistant infections. The company has created a platform technology called antimicrobial photodynamic disinfection, or photodisinfection, to help prevent and help treat infections across different therapeutic areas in healthcare and industry settings. Canada is the major revenue generator for the group. The company has one reportable operating segment that is antimicrobial photodynamic therapy (aPDT) products.

  • Contact

    1100 Melville Street
    Suite 888
    VancouverBCV6E4A6
    CAN

    T: +1 604 669-0555

    E: [email protected]

    https://www.ondinebio.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    8,000

Stocks News & Analysis

stocks

Insignia Financial: Revised deal still attractive

The offer price is well above our fair value.
stocks

Undervalued ASX income play

Major development projects remain on schedule.
stocks

Going into earnings, is Alphabet stock a buy, a sell, or fairly valued?

With the monetization of GenAI, here’s what we think of Alphabet’s stock

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,001.4059.900.67%
CAC 407,827.3482.931.07%
DAX 4024,214.87172.970.72%
Dow JONES (US)44,502.44179.370.40%
FTSE 1009,058.2734.460.38%
HKSE25,490.47360.441.43%
NASDAQ20,892.6981.49-0.39%
Nikkei 22541,171.321,396.403.51%
NZX 50 Index12,794.0639.68-0.31%
S&P 5006,309.624.020.06%
S&P/ASX 2008,737.2060.000.69%
SSE Composite Index3,582.300.440.01%

Market Movers